lacked endogenous synapsin I-immunopositive presynaptic terminals ( fig. S7 ). Further, HACbln1-coated beads induced clustering of GluD2 and GluD2 ext -GluK2, but not GluD2 DNTD , GluK2, or GluK2 ext -GluD2, in HEK293 cells ( fig. S8 ). The C terminus of GluD2 interacts directly with several intracellular molecules, such as shank-2 (15) and PSD-93/95 (16) ; many of these serve as scaffolds for other postsynaptic molecules, including homer-3, transmembrane AMPA receptor regulatory protein (TARP), and AMPA glutamate receptors (GluAs). Thus, we examined if the clustering of GluD2 induced by the Cbln1-coated beads might accumulate with other postsynaptic molecules in Purkinje cells. With GluD2, shank-2, homer-3, and GluA2 clustered in Purkinje cells around the beads coated with HA-Cbln1 (Fig. 4B) . In contrast, HA-Cbln1-coated beads did not accumulate gephyrin [an anchoring protein for the g-aminobutyric acid (GABA) receptor] (Fig. 4B ) or excitatory amino acid transporter 4 (EAAT4, a neuronal glutamate transporter) ( fig. S9 ) in Purkinje cells. HACbln1-coated beads did not induce clustering of shank-2 or GluA2 in cbln1/GluD2-null Purkinje cells (Fig. 4C ). Shank-2 and PSD-95 accumulated around HA-Cbln1-coated beads only when the responsible C-terminal domains of GluD2 were intact (fig. S10).
To further identify a role for Cbln1 as a postsynaptic organizer in vivo, we examined if the distribution of GluD2 was affected in cbln1-null Purkinje cells using the SDS-digested freeze-fracture replica labeling (SDS-FRL) method, which has a nearly one-to-one detection sensitivity for each iGluR on the surface of the postsynaptic membrane specialization (17) . To exclude a possible effect of the presence of noninnervated spines in the cbln1-null cerebellum (Fig. 2C) , we counted the number of immunoparticles detected by GluD2-specific antibody (fig. S11) in intact synapses, which were accompanied by the presynaptic protoplasmic face. The number of GluD2 immunoparticles located on postsynaptic membranes was significantly reduced in cbln1-null Purkinje cells ( Fig. 4D , P < 0.001), which indicated that Cbln1 serves as a postsynaptic organizer in vivo and contributes to the clustering of postsynaptic GluD2.
We have demonstrated that Cbln1 is a ligand for the orphan receptor GluD2. Among known synapse-organizing molecules, such as neuroliginneurexin (18), SynCAM-SynCAM (19), EphrinBEphB (20) , fibroblast growth factor (FGF) 22-FGF receptor 2b (21), Narp-GluAs (22) , and netrin-G ligand-3 and leukocyte common antigenrelated (NGL-3-LAR) (23), Cbln1-GluD2 signaling is unique in that without each component, synapse formation was severely abrogated in the cerebellum in vivo as well as in heterologous cells in vitro. Its bidirectional mode of action is also unique; at synaptic junctions, presynaptically derived Cbln1 accumulates and directly induces presynaptic differentiation, possibly by interacting with unidentified proteins on the presynaptic membrane (Fig. 4E) . Because beads coated with HA-Cbln1 induced accumulation of functional presynaptic terminals (Fig. 3) , GluD2 may simply serve as a scaffold to accumulate and stabilize Cbln1 at synaptic junctions. Conversely, Cbln1 probably serves as a postsynaptic organizer by clustering GluD2, which may regulate synaptic plasticity via its interacting intracellular proteins (24) .
Cbln1 is also expressed in various brain regions where GluD2 is not expressed, such as the olfactory bulb, the entorhinal cortex, and certain thalamic nuclei (25) , which indicates that Cbln1 may bind to other receptors in these regions. An alternative candidate receptor is GluD1, which is highly expressed in these brain regions, especially during development (26 (5) . Second, mutations leading to the fusion of protein-coding genes may lead to the improper activation of signaling networks that result in oncogenic transformations (6, 7) . Third, fusions of diverse regulatory and catalytic domains can yield synthetic proteins with non-natural input/output relationships, both in vitro (8) and in vivo (9) (10) (11) .
To investigate whether recombination of signaling protein domains provides a route for evolutionary innovation, analogous to the swapping of cis-regulatory elements and coding sequences in transcriptional circuits (12) (13) (14) , we have systematically determined the effects of domain recombination on the behavior of a well-understood signaling network, the yeast mating pathway (Fig. 1A) , and compared it to the effects brought about by gene or domain duplication. We used the domains of 11 proteins belonging to the mating pathway to construct a library of 66 recombinant proteins (Fig. 1B) . Specifically, all native proteins composed of at least two domains were split in a manner that separated regulatory and catalytic domains. The split points were chosen to ensure that domains were left intact and therefore are located within interdomain connecting regions. We then created a library of chimeric proteins that includes all possible recombinations of N-terminal and C-terminal blocks to systematically map the resulting phenotypic effects (Fig. 1C and fig. S1 ). Each protein was transformed into a yeast strain that retained the endogenous copies of the 11 mating pathway genes, such that an additional protein (with altered domain combination) was added to the existing network. To distinguish the effects of domain recombination from those of gene or domain duplication, we created three additional sets of strains ( Fig. 1D ): In the first one, each of the 11 genes analyzed was duplicated; in the second one, each of the N-or C-terminal blocks was duplicated; and in the third one, each possible pair of N-and C-terminal blocks were duplicated and coexpressed (all 66 combinations lacking domain recombination). To prevent any bias that might be related to differential transcriptional control, we expressed all constructs at low abundance using a 250 base pair segment of the constitutive cycI promoter.
As a metric for how each additional protein altered signaling behavior, we measured the dynamics of mating pathway activation by flow cytometry. A green fluorescent protein (GFP) reporter was controlled by a mating-responsive promoter from the fus1 gene (15) in an a-type, Dfar1 strain [to prevent cell cycle arrest and the formation of mating projections that could affect flow cytometry measurements (16)]. We measured the intensity of GFP fluorescence before and after activation of the mating pathway with a-factor and used those values to calculate the baseline and slope of activation ( Fig. 2A) . The normalized baseline and slope values for each variant in our libraries (relative to wild type) were plotted on a "morphospace" diagram. Gene and domain duplications had little effect on the dynamics of pathway activation (Fig. 2 , B and C). Only three domain duplication variants showed changes, slightly inhibiting pathway activation (variants with lower slopes in Fig. 2C ), perhaps by acting as dominant negative fragments. In contrast, recombination of domains resulted in Fig. 1 . Design of the recombination library of protein domains belonging to the yeast mating pathway. (A) The yeast mating pathway is activated by binding of the mating pheromone (a-factor) to the membrane receptor Ste2 in "a" cells (or a-factor to Ste3 in "a" cells), which causes the dissociation of the G protein alpha subunit (GpaI) from the G beta (Ste4) and gamma (Ste18) complex (20, 25) . The scaffold protein Ste5 is then recruited to the membranelocalized Ste4, bringing along the MAPKKK Ste11, MAPKK Ste7, and MAPK Fus3. In addition, Ste11 interacts with the bridging protein Ste50, which by binding to the small guanosine triphosphatase (GTPase) Cdc42, positions Ste11 near its upstream activator, the PAK kinase Ste20 (26) . Activated Ste11 phosphorylates Ste7, which in turn phosphorylates Fus3. The activated MAPK translocates to the nucleus, where it phosphorylates a number of transcription factors, leading to changes in gene transcription, cell cycle progression, and cell morphology and culminating in the fusion between "a" and "a" cells. (Fig. 2D) . These altered signaling behaviors appear to depend on domain recombination, because coexpression of all analogous pairs of unlinked N-and C-terminal domain blocks had limited effects on pathway activation (Fig. 2E) 
Types of Genetic Changes Analyzed in this Study
Beyond changes in gene expression, activation of the mating pathway leads to a coordinated response that arrests cell cycle, alters cell morphology, and ultimately results in the fusion of mating partners (20) . To determine whether changes in reporter gene expression dynamics caused by domain recombination were mirrored by changes in overall pathway outcome, we measured the efficiency with which "a" strains, expressing domain recombination variants, mated with wild-type "a" cells. We focused on the 10 recombination variants with dynamic behaviors most different from wild type and from the corresponding coexpressed N-and C-domain pair (figs. S3 and S4) and measured the percentage of "a" cells that successfully mated when coincubated with "a" cells (21) . Yeast strains expressing domain recombination variants with slopes of pathway activation greater than that of wild type mated more efficiently than did wild-type yeast ( Fig. 3A and table S1 ). The same was true for one variant with high baseline of pathway activation but slightly lower slope (Ste4[N]-Ste5[C]). In contrast, yeast strains expressing variants with activation slopes lower than that of wild type mated more poorly. The observed changes in mating efficiency also appeared to depend on domain recombination, because there were marked differences between the mating efficiencies of corresponding recombination and coexpression variants (Fig. 3B) . Thus, domain recombination can alter complex pathway outputs, such as the biochemical and morphological changes needed for mating. At least under laboratory conditions, recombination of protein domains can lead to strains that mate more efficiently than wild type, although further work is needed to determine whether the changes in mating efficiency we observed could confer a selective advantage.
Activation of the mating pathway response alters the regulation of the cell cycle (16) . In addition, the mating pathway shares several proteins with other signaling pathways, such as the high osmolarity pathway. Thus, domain recombination variants that alter the mating pathway response could also have pleiotropic effects on other cellular processes. To investigate this possibility, we measured growth rate, as well as the response to high osmolarity stimulus, for the recombination variants that most substantially affected mating response. We found that variants with growth rate deficiencies of only 2 to 3% compared to wild type ( fig.  S5A ) mate up to~3 times better than wild type. This suggests that, in some cases and under laboratory conditions, the cost in asexual growth likely imposed by recombination-induced network remodeling could be compensated in part by the benefit in mating efficiency it confers ( fig. S5B ). In addition, we observed that the response to high osmolarity is only marginally affected ( fig. S5C ). We cannot rule out the possibility that some of the variants analyzed might have detrimental effects on other signaling pathways or cellular processes. Signaling responses are often characterized by their dynamics of temporal activation, as well as by the specific dose-response profile: Whereas some pathways follow a graded dose response, others have switch-like activation profiles (22) . To explore whether domain recombination could also alter the dose-response profile, we measured pathway response at different concentrations of pheromone for two of the domain recombination variants that most markedly affected the mating pathway temporal response. S6B ). These results suggest that domain recombination might slightly alter the sensitivity of the mating pathway to pheromone levels.
We investigated the mechanisms by which recombination variants might alter the dynamics of the response. We first measured protein abundance for some duplication or recombination variants and found that there is no clear correlation between changes in mating response and protein abundance ( fig. S7 ). Mating pathway signaling requires interactions between three major functional complexes: the membrane-bound G protein complex, the mitogen-activated protein kinase (MAPK) complex, and the membranebound polarity complex (Fig. 1) . Recruitment of the MAPK complex to the membrane, by its interaction with the G protein complex, positions the MAPKKK, Ste11, close to its p21-activated protein kinase (PAK) kinase activator, Ste20 (also referred to as the MAPKKKK), a member of the polarity complex (20, 23) .
Close examination of the 10 recombination variants that most markedly changed signaling behavior revealed that 7 of the 10 created novel links between the different signaling complexes, whereas only three created linkages within an individual functional complex (Fig. 4A) . Thus, new behaviors may arise when key components change in their localization or complex formation. To explore this hypothesis, we examined three recombinant variants in greater detail. The Ste20[N]-Ste11[C] fusion [which tethers the Cdc42 binding domain of Ste20 to the kinase domain of Ste11 ( fig. S8) ] resulted in higher baseline output (Fig. 4B ). This fusion protein may result in the recruitment of Ste11 kinase domain to the polarity complex, even in the absence of a-factor stimulation, where it can be constitutively activated by Ste20 [the MAPKKKK ( fig. S9A) ]. This relocalization to sites of polarity was confirmed by microscopy experiments with the GFP-labeled fusion protein (Fig. 4C) fig. S8 )] resulted in a large increase in the slope of output (Fig. 4D) . This fusion may result in an additional population of Ste11 kinase domain that, because it is covalently fused to Ste5 [N] , is more efficiently recruited to the membrane upon a-factor stimulation, which may increase signaling ( fig. S9B ). Microscopy studies confirmed that this fusion protein is inducibly localized to membrane sites of polarization (Fig.  4E ). The Ste50[N]-Ste20[C] fusion [which tethers Ste11 binding sterile alpha motif (SAM) domain of Ste50 to the kinase domain of Ste20 (Fig. S8) ] resulted in high constitutive activation (Fig. 4F ). This fusion protein may bring the Ste20 kinase domain to the MAPK complex, where it will constitutively activate Ste11 and trigger the MAPK cascade, without the need for membrane recruitment of the MAPK complex ( fig. S9C ). Microscopy studies confirmed that this fusion localizes to the cytoplasm both with and without a-factor stimulation (Fig. 4G) . Overall, these more detailed observations are consistent with a model in which shuffling of a catalytic domain with different regulatory domains results in novel regulation or localization of the catalytic domain, leading to distinct changes in signaling behavior and cellular phenotype.
The high frequency with which the limited diversity encoded in our recombination library led to novel signaling behaviors suggests that domain recombination might have an important role in the generation of phenotypic novelty from simple genotypic changes and could likely complement the role of cis-regulatory elements in the evolution of global cellular regulatory networks composed of both transcriptional and signaling elements (24) . Further work will be needed to compare in quantitative terms the contributions of gene duplication and recombination to the evolutionary process. The strategy used here of targeted domain recombination between proteins that belong to a specific signaling network could facilitate the engineering of other protein networks of interest, a fundamental goal of synthetic biology. Genes known to belong to a target pathway could be deconstructed into domains and used to build small libraries of domain recombinations that are subsequently screened for the desired function.
